%0 Journal Article
%A Vallès, Ermengol
%A Jiménez, Jesús
%A Martí-Almor, Julio
%A Toquero, Jorge
%A Ormaetxe, José Miguel
%A Barrera, Alberto
%A García-Alberola, Arcadio
%A Rubio, José Manuel
%A Moriña, Pablo
%A Grande, Carlos
%A Fé Arcocha, Maria
%A Peinado, Rafael
%A Cózar, Rocío
%A Hernández, Julio
%A Pérez-Alvarez, Luisa
%A Gaztañaga, Larraitz
%A Ferrero-De Loma-Osorio, Angel
%A Ruiz-Granell, Ricardo
%A Villuendas, Roger
%A Martínez-Alday, Jesús Daniel
%T Cryoballoon Ablation for Persistent and Paroxysmal Atrial Fibrillation: Procedural Differences and Results from the Spanish Registry (RECABA).
%D 2022
%@ 2077-0383
%U http://hdl.handle.net/10668/21243
%X Introduction: Cryoballoon ablation (CBA) has become a standard treatment for paroxysmal atrial fibrillation (PaAF) but limited data is available for outcomes in patients with persistent atrial fibrillation (PeAF). Methods: We analyzed the first 944 patients included in the Spanish Prospective Multi-center Observation Post-market Registry to compare characteristics and outcomes of patients undergoing CBA for PeAF versus PaAF. Results: A total of 944 patients (57.8 ± 10.4 years; 70.1% male) with AF (27.9% persistent) were prospectively included from 25 centers. PeAF patients were more likely to have structural heart disease (67.7 vs. 11.4%; p
%K cryoballoon procedure
%K persistent atrial fibrillation
%K registry
%~